The 14 references in paper V. Sipovskyi G., V. Dobronravov A., A. Karunnaya V., A. Smirnov V., В. Сиповский Г., В. Добронравов А., А. Корунная В., А. Смирнов В. (2013) “КЛИНИКО-МОРФОЛОГИЧЕСКИЙ АНАЛИЗ ИЗМЕНЕНИЙ ПЕРИТУБУЛЯРНЫХ МИКРОСОСУДОВ ИНТЕРСТИЦИЯ ПОЧЕК У БОЛЬНЫХ IgA-НЕФРОПАТИЕЙ (IgAN) С ОЦЕНКОЙ АКТИВНОСТИ ЛЕКТИНОВОГО ПУТИ СИСТЕМЫ КОМПЛЕМЕНТА // CLINICAL AND MOTPHOLOGIVAL ANALYSIS OF CHANGES OF PERITUBULAR MICROCIRCULATION VESSELS OF FIDNEY INTERSTITIAL TISSUE IN PATIENTS WITH IGA-NEPHROPATHY (IGAN) WITH ESTIMATION OF LECTIN PATHWAY OF COMPLEMENT ACTIVATION” / spz:neicon:nefr:y:2013:i:4:p:89-94

1
Naumovic R. Renal biopsy registry from a single centre in Serbia: 20 years of experience. Nephrol Dial Transplant 2009;
(check this in PDF content)
2
877-885 2. D’Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004; 24; 179-196
(check this in PDF content)
3
Kobayashi Y, TatenoS, Hiki Y at al. IgA nephropathy: prognostic significance of proteinuriaand histological alterations. Nephron 1983; 34: 146-153
(check this in PDF content)
4
Dobbelsteen MEA, Van Der Woude FJ, Schroeijers WEM et al. Binding of dimeric and polymeric IgA to rat renalmesangial cells enchances the release of interleukin 6. Kidney Int 1994; 46: 512-519
(check this in PDF content)
5
Espinosa M, Ortega R, Gomez-Carrasco MJ et al. Mesamgial C4d deposition:a new prognostic factor in IgA nephropathy. Nephrol Dial Transplant 2009; 24: 886-891
(check this in PDF content)
6
Roos A, Rastaldi MP, Calvares N et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 2006;17:1724-34
(check this in PDF content)
7
Arrizabalga P, Sole M, Quito l, et al. Leukocyte infiltration and intercellular adhesion molecule-1-mediated cell interactions in immunoglobulin A nephropathy. Arch Pаthol Lab Med 1998; 122: 817-22
(check this in PDF content)
8
Chan LY, LeungJC, Lai KN. Novel mechanism of tubulointerstitial injury in IgA nephropathy: a new therapeutic paradigm in the prevention of progressive renal failure. Clin Exp Nephrol 2004; 8: 297-303
(check this in PDF content)
9
Li PK, Ho KK, Szeto CC et al. Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives. Nephrol Dial Transpant 2002; 17: 64-69
(check this in PDF content)
10
D’Agati VD, Janne e JCh, Silva FG. ATLAS Non-neoplastic kidey disease: IgA Nephropathy and Henoch-Schonlein Purpura. AFIP, Washington, ARP Press 2005; 297-323
(check this in PDF content)
11
Ibels LS,Gyory AZ. IgA nephropathy :analysis of the natural history important factors in the progression of renal disease and a review of the literature. Medicine1994;73: 79-102
(check this in PDF content)
12
Endo M, Ohi H, Oshawa I et al.Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrol Dial Transplant 1998; 13: 1984-1990
(check this in PDF content)
13
Solez K, Colvin RB, Racusen LC et al. BANFF 07 classification of Renal Allograft Pathology: Updates and Future Directions. Am J Transplat 2008; 8: 753-760
(check this in PDF content)
14
Hisano S, Matsushita M, Fujita T et al. Activation of the lectin complement pathway Henoch-Shomlein purpura nephritis. Am J Kidney Dis 2005; 45: 295-302 Поступила в редакцию 07.06.2013 г. Принята в печать 02.07.2013 г.
(check this in PDF content)